[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334002-105":59,"doc-detail-334002-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","discovery-of-jaspamycin-from-marine-derived-natural-product-based-on-mta3-to-inhibit-hepatocellular-carcinoma-progression","Discovery of Jaspamycin from marine-derived natural product based on MTA3 to inhibit hepatocellular carcinoma progression","","Studies highlight metastasis-associated protein 3 (MTA3) as a cancer regulator, motivating systematic evaluation of its drug-target potential across cancers. The work analyzes MTA3 expression profiles for diagnostic and prognostic value across pan-cancers, linking MTA3 with genetic alterations and immune features, with liver hepatocellular carcinoma showing the strongest association. siRNA silencing reveals MTA3 controls HepG2 and Hepa1-6 viability and migration. Through screening marine-derived natural products, Jaspamycin is identified as an MTA3-targeting inhibitor that suppresses hepatocellular carcinoma progression in vitro and in vivo, while MTA3 overexpression counteracts Jaspamycin effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/discovery-of-jaspamycin-from-marine-derived-natural-product-based-on-mta3-to-inhibit-hepatocellular-carcinoma-progression/334002/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/discovery-of-jaspamycin-from-marine-derived-natural-product-based-on-mta3-to-inhibit-hepatocellular-carcinoma-progression/334002.png","ImageObject",300,407,{"name":92,"@type":93},"Sage","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is MTA3 considered a potential drug target?","Question",{"text":112,"@type":113},"MTA3 is a metastasis-associated protein whose activity is linked to cancer progression, and it shows distinct roles across cancer types. The study evaluates whether MTA3 can support both diagnosis/prognosis and therapeutic targeting.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the study test the role of MTA3 in hepatocellular carcinoma?",{"text":117,"@type":113},"The authors used siRNA to interfere with MTA3 and measured effects on hepatocellular carcinoma cell viability and migration in HepG2 and Hepa1-6 cells.",{"name":119,"@type":110,"acceptedAnswer":120},"What is Jaspamycin and how does it work in the study?",{"text":121,"@type":113},"Jaspamycin was identified from marine-derived natural products as a compound that targets MTA3. Experiments show it inhibits hepatocellular carcinoma viability, migration, and tumor progression, while MTA3 overexpression reduces its inhibitory effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334002,1791535617,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},687197207057,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDiscovery of Jaspamycin from marine-derived natural product based on MTA3 to inhibit hepatocellular carcinoma progression  \nYihan Liu1, Tong Lu2, Runze Li3, Rui Xu4, Denis Baranenko5, Lida Yang6 & Dan Xiao3,7,8􀀍  \nStudies have underscored the pivotal role of metastasis-associated protein 3 (MTA3) as a cancer regulator, yet its potential as a drug target across cancers necessitates comprehensive evaluation. In this study, we analyzed MTA3 expression profiles to ascertain its diagnostic and prognostic value in pan-cancers, probing associations with genetic variations and immunological characteristics. Notably, liver hepatocellular carcinoma (LIHC) exhibited the most significant correlation with MTA3 . By transfection of siRNA, interference of MTA3 affected HepG2 and Hepa1-6 cell viability and migration. Through drug screening and drug-likeness evaluation among marine-derived natural products, Jaspamycin was identified as a potential hepatocellular carcinoma treatment by targeting MTA3 . By applying in vitro and in vivo experiment, the inhibitory effects of Jaspamycin on hepatocellular carcinoma viability, migration, and tumor progression were observed. To assess the potential of MTA3 as an anticancer drug target, MTA3 overexpression plasmid was transfected together with Jaspamycin treatment, and observed that MTA3 upregulation counteracted the inhibitory effects of Jaspamycin on hepatocarcinoma cell proliferation and migration, underscoring the efficacy of MTA3 as a drug target in hepatocellular carcinoma drug screening. This study highlights the clinical significance of MTA3 in pan-cancer, particularly in hepatocellular carcinoma. Additionally, it identifies Jaspamycin, a marinederived compound with promising pharmacological properties, as an effective inhibitor of MTA3 activity, suggesting its potential for hepatocellular carcinoma treatment.  \nKeywords MTA3, Pan-cancer, Hepatocellular carcinoma, Marine-derived anticancer agent, Jaspamycin  \nMarine-derived natural products have garnered significant attention within the medical community due to their distinct chemical structures and biological activities. Over recent decades, scientists have unearthed numerous bioactive molecules from oceanic sources, unveiling their potential roles in cancer therapy and opening up new avenues for cancer treatment. For instance, Plocabulin, extracted from the sponge Lithoplocamia lithistoides, is presently undergoing phase II clinical trials for the treatment of advanced solid tumors1. Marine natural products are believed to possess heightened bioactivity and bioavailability, presenting immense potential for the discovery of novel anticancer drugs2,3. However, the translation of marine-derived natural products into clinically applicable anticancer drugs encounters several challenges, including the screening of natural products, assessment of biological activity, pharmacological investigation, among others challenges. Consequently,  \n1Graduate School, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150001, China. 2Medical Technology Department, Qiqihar Medical University, Qiqihar, Heilongjiang 161006, China. 3National and Local Joint Engineering Laboratory for Synthesis Transformation and Separation of Extreme Environmental Nutrients, Harbin Institute of Technology, Harbin, Heilongjiang 150001, China. 4Cancer Hospital, Shenzhen Hospital, National Cancer Center, National Clinical Research Center for Cancer, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen 518116, Guangdong, China. 5School of Life Sciences, Faculty of Ecotechnologies, ITMO University, St. Petersburg 197101, Russia. 6Heilongjiang Nursing Collage, Harbin, Heilongjiang 150086, China. 7Zhengzhou Research Institute, Harbin Institute of Technology, Zhengzhou, Henan 450007, China. 8School of Medicine and Health, Harbin Institute of Technology, No. 92, Xidazhi St","cbCaiqUKwrn2LQMX","https://ap.wps.com/l/cbCaiqUKwrn2LQMX","pdf",5425563,21,"English","# Background\n## Marine-derived natural products in cancer research\n## Pan-cancer analysis for therapeutic discovery\n## Role of MTA3 in cancer progression\n# MTA3 evaluation and functional experiments\n## MTA3 expression profiles and clinical relevance\n## siRNA-mediated MTA3 interference in cell assays\n# Jaspamycin identification and validation\n## Screening and drug-likeness assessment\n## In vitro and in vivo anti-tumor effects\n## MTA3 overexpression rescue experiments","[{\"question\":\"Why is MTA3 considered a potential drug target?\",\"answer\":\"MTA3 is a metastasis-associated protein whose activity is linked to cancer progression, and it shows distinct roles across cancer types. The study evaluates whether MTA3 can support both diagnosis/prognosis and therapeutic targeting.\"},{\"question\":\"How did the study test the role of MTA3 in hepatocellular carcinoma?\",\"answer\":\"The authors used siRNA to interfere with MTA3 and measured effects on hepatocellular carcinoma cell viability and migration in HepG2 and Hepa1-6 cells.\"},{\"question\":\"What is Jaspamycin and how does it work in the study?\",\"answer\":\"Jaspamycin was identified from marine-derived natural products as a compound that targets MTA3. Experiments show it inhibits hepatocellular carcinoma viability, migration, and tumor progression, while MTA3 overexpression reduces its inhibitory effects.\"}]","Discovery of Jaspamycin from marine-derived natural product based on MTA3 to inhibit hepatocellular carcinoma progression | PDF",1790004959,53]